Role of protein kinase C-iota in transformed non-malignant RWPE-1 cells and androgen-independent prostate carcinoma DU-145 cells

Cell Proliferation

Volumn 42, Issue 2, 2009, Pages 182-194

  Win, H Y ^b   Acevedo Duncan, M ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CASPASE 7; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 7; CYTOCHROME C; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAD; PROTEIN BCL XL; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; PROTEIN KINASE C GAMMA; PROTEIN KINASE C IOTA; SERINE; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL SURVIVAL; CELL TRANSFORMATION; CELL VIABILITY; CONTROLLED STUDY; DIMERIZATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME RELEASE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MALE; NUCLEOTIDE SEQUENCE; PROSTATE CARCINOMA; PROTEIN CLEAVAGE; WESTERN BLOTTING;

APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; BCL-X PROTEIN; CELL COUNT; CELL CYCLE; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASES; HUMANS; ISOENZYMES; MALE; PHOSPHORYLATION; POLY(ADP-RIBOSE) POLYMERASES; PROSTATE; PROSTATIC NEOPLASMS; PROTEIN KINASE C; RNA, SMALL INTERFERING;

EID: 62449305125     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2009.00582.x     Document Type: Article

References (53)

1. Murray NR, Fields AP (1997) Atypical protein kinase C ι protects human leukemia cells against drug-induced apoptosis. J. Biol. Chem. 272, 27521 27524.
2. Cornford P, Evans J, Dodson A, Parsons K, Woolfenden A, Neoptolemos J, Foster CS (1999) Protein kinase C isozyme patterns characteristically modulated in early prostate cancer. Am. J. Pathol. 154, 137 144.
3. Yuichi TM, Gavrielides V, Mitsuuchi Y, Fujii T, Kazanietz MG (2003) Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway. J. Biol. Chem. 278, 33753 33762.
4. Jamieson L, Carpenters L, Biden TJ, Fields AP (1999) Protein kinase Cι activity is necessary for Bcr-Abl-mediated resistance to drug-induced apoptosis. J. Biol. Chem. 274, 3927 3930.
5. Acevedo-Duncan M, Patel R, Whelan S, Bicaku E (2002) Human glioma PKC-ι and PKC-βII phosphorylate cyclin-dependent kinase activating kinase during the cell cycle. Cell Prolif. 35, 23 36.
6. Bicaku E, Acevedo-Duncan M (2001) Ultrastructural study of protein kinase C-βII localization during the cell cycle of human glioma cells. Tissue Cell 33, 55 62.
7. Zhaohui J, Meiguo X, Xingming D (2005) Survival function of protein kinase Cι as a novel nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone-activated Bad kinase. J. Biol. Chem. 290, 16045 16052.
8. Stallings-Mann M, Jamieson L, Regala RP, Weems C, Murray NR, Fields AP (2006) A novel small-molecule inhibitor of protein kinase Cι blocks transformed growth of non-small-cell lung cancer cells. Cancer Res. 66, 1761 1774.
9. Regala RP, Weems C, Jamieson L, Copland JA, Thompson EA, Fields AP (2005) Atypical protein kinase Cι plays a critical role in human lung cancer cell growth and tumorigenicity. J. Biol. Chem. 280, 31109 31115.
10. Gustafson WC, Ray S, Jamieson L, Thomson EA, Brasier AR, Fields AP (2004) Bcr-Abl regulates protein kinase Cι (PKCι) transcription via an Elk1 site in the PKC-ι promoter. J. Biol. Chem. 279, 9400 9408.
11. Choi WC, Ahn CH (1993) Protein kinase C (PKC) in cellular signaling system: translocation of six protein kinase C isozymes in human prostate adenocarcinoma PC-3 cell line. Korean J. Zool. 36, 439 451.
12. Henttu P, Vihko P (1998) The protein kinase C activator, phorbol ester, elicits separate functional responses in androgen-sensitive and androgen-independent human prostatic cancer cells. Biochem. Biophys. Res. Comm. 244, 167 171.
13. Gonzalez-Guerrico AM, Meshki J, Xiao L, Benavides F, Conti CJ, Kazanietz MG (2005) Molecular mechanisms of protein kinase C-induced apoptosis in prostate cancer cells. J. Biochem. Mol. Biol. 38, 639 645.
14. Powell CT, Brittis NJ, Stec D, Hug H, Heston WD, Fair WR (1996) Persistent membrane translocation of protein kinase C α during 12-0-tetradecanoylphorbol-13-acetate-induced apoptosis of LNCaP human prostate cancer cells. Cell Growth Differ. 7, 419 428.
15. Fuji T, Garcia-Bermejo ML, Bernabo JL, Caamaon J, Ohba M, Kuroki T, Li L, Yuspa SH, Kazanietz MG (2000) Involvement of protein kinase C δ (PKCδ) in phorbol ester-induced apoptosis in LNCaP prostate cancer cells. J. Biol. Chem. 275, 7574 7582.
16. Haldar S, Chintapalli J, Croce CM (1996) Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res. 56, 1253 1255.
17. Bookstein R, Shew JY, Chen PL, Scully P, Lee WH (1990) Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated Rb gene. Science 247, 712 715.
18. xL blocks transforming growth factor-β1-induced apoptosis by inhibiting cytochrome c release and not by directly antagonizing apaf-1-dependent caspase activation in prostate epithelia cells. J. Biol. Chem. 276, 26614 26621.
19. Gross A, McDonnell JM, Korsmeyer SJ (1999) Bcl-2 family members and the mitochondria in apoptosis. Genes Dev. 13, 1899 1911.
20. Virdee K, Parone PA, Tolkovsky AM (2000) Phosphorylation of the pro-apoptotic protein BAD on serine 155, a novel site, contribute to cell survival. Curr. Biol. 10, 1151 1154.
21. Tan Y, Demeter MR, Ruan H, Comb MJ (2000) Bad ser-155 phosphorylation regulates BAD/Bcl-XL interaction and cell survival. J. Biol. Chem. 275, 25865 25869.
22. Yang CC, Lin HP, Chen CS, Yang YT, Tseng PH, Rangnekar VM, Chen CS (2003) Bcl-xL mediates a survival mechanism independent of the phosphoinostide 3-kinase/Akt pathway in prostate cancer. J. Biol. Chem. 278, 25872 25878.
23. 155. J. Biol. Chem. 275, 25046 25051.
24. Irina L, Robert R, Joshua O, Paul C, Stein CA (2000) Bcl-xL in prostate cancer cells: effects of overexpression and down regulation of chemosensitivity. Cancer Res. 60, 6052 6090.
25. Raffo AJ, Perlman H, Chen MW, Day ML, Streitman JS, Buttyan R (1995) Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. Cancer Res. 55, 4438 4445.
26. Dean GT, Li L, Dharam PC, Arthur TP (1998) Extended survivability of prostate cancer cells in the absence of trophic factors: increase proliferation, evasion of apoptosis, and the role of apoptosis proteins. Cancer Res. 58, 3466 3479.
27. Kazuki Y, Palma R, Hideaki M, Ladan F, Alan S, Uwe ZW, Martin EG (2006) Induction of apoptosis and enhancement of chemosensitivity in human prostate cancer LNCaP cells using bispecific antisense oligonucleotide targeting Bcl-2 and Bcl-xL genes. BJU Int. 97, 13000 11308.
28. Carlton JC, Terry NHA, White A (1991) Measuring potential doubling times of murine tumors using flow cytometry. Cytometry 12, 645 6450.
29. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248 254.
30. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 237, 680 685.
31. Towbin H, Staehelin T, Gordon PE (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl Acad. Sci. USA 76, 4350 4354.
32. Bello D, Webber MM, Kleinman HK, Wartinger DD, Rhim JS (1997) Androgen responsive adult human prostate epithelial cell lines immortalized by papillomavirus 18. Carcinogenesis 18, 1215 1223.
33. Webber MM, Bello D, Quader S (1997) Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications. Part 2. Tumorigenic cell lines. Prostate 30, 58 64.
34. 1 arrest and apoptosis in human prostate carcinoma cells. Cancer Res. 65, 1035 1044.
35. 1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells. Mol. Cancer Ther. 5, 296 308.
36. Downward J (1999) How Bad phosphorylation is good for survival. Nat. Cell Bio. 1, E33 E35.
37. Gao N, zhang Z, Jiang BH, Shi X (2003) Role of PI3/AKT/mTOR signaling in the cell cycle progression of human prostate cancer. Biochem. Biophys. Res. Commun. 4, 1124 1132.
38. Teruhiki F, Maria LGB, Juan LB, Jorge C, Motoi O, Toshio K, Luowei Li Stuart HY, Marcelo GK (2000) Involvement of protein kinase C δ (PKC δ) in phorbol ester-induced apoptosis in LNCaP prostate cancer cells. J. Biol. Chem. 275, 7574 7582.
39. Kerr JFK, Wyllie AH, Currie AH (1972) Apoptosis, a basic biological phenomenon with wider implication in tissue kinetics. Br. J. Cancer 26, 239 245.
40. Wyllie AH, Keer JFK, Currie AR (1980) Cell death: the significance of apoptosis. Int. Rev. Cytol. 68, 251 306.
41. Chipuk JE, Green DR (2005) Do inducers of apoptosis trigger caspase-independent cell death? Nature 6, 268 275.
42. Kaufmann S, Desnoyers S, Ottaviano Y, Davidson N, Poirier G (1993) Specific proteolytic cleavage by poly (ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res. 53, 3976 3985.
43. Green GR, Reed JC (1998) Mitochondria and apoptosis. Science 283, 1309 1312.
44. Marchetti P, Castedo M, Susin SA et al 1996) Mitochondrial permeability transition is a central coordinating event of apoptosis. J. Exp. Med. 184, 1155 1160.
45. Grossman D, Kim PJ, Blanc-Brude OP, Brash DE, Tognin S, Marchisio PC, Altieri DC (2001) Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53. J. Clin. Invest. 108, 991 999.
46. Mesri M, Wall NR, Li J, Kim RW, Altieri DC (2001) Cancer gene therapy using surviving mutant adenovirus. J. Clin. Invest. 108, 981 990.
47. Ying L, Lee J, Allan RB, Alan PF (2001) NF-κB/RelA transactivation is required for atypical protein kinase Cι-mediated cell survival. Oncogene 20, 4777 4792.
48. Sandeep RD, Alex K, Linda H, Andrew P, Stephen WF, Michael BY, Micahel EG (2000) 14-3-3 proteins and survival kinases cooperate to inactivate Bad by BH3 domain phosphorylation. Mol. Cell 6, 41 51.
49. L. Cell 87, 619 628.
50. Oltvai ZN, Korsmeyer SJ (1994) Checkpoints of dueling dimmers foil death wishes. Cell 79, 189 192.
51. Amarante-Mendes GP, McGahon AJ, Nishioka WK, Afar DEH, Witte ON, Green GR (1998) Bcl-2-independent Bcr-Abl-mediated resistance to apoptosis: protection is correlated with up regulation of Bcl-xL. Oncogene 16, 1383 1390.
52. Larisch-Bloch S, Danielpour D, Roche NS, Lotan R, Hsing AY, Kerner H, Hajouj T, Lechleider RJ, Robers AB (2000) Selective loss of the transforming growth factor-β apoptotic signaling pathway in mutant NRP-154 rat prostatic epithelial cells. Cell Growth Differ. 11, 1 10.
53. Basu A, Haldar S (2003) Identification of a novel Bcl-xL phosphorylation site regulating the sensitivity of taxol- or 2-methoxyestradiol-induced apoptosis. FEBS Lett. 538, 41 47.